At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...
The trial of two adoptive dads following the death of baby Preston Davey has continued today (June 1). Jamie Varley, 37, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results